These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30587940)

  • 1. Association of medication adherence and depression with the control of low-density lipoprotein cholesterol and blood pressure in patients at high cardiovascular risk.
    Katzmann JL; Mahfoud F; Böhm M; Schulz M; Laufs U
    Patient Prefer Adherence; 2019; 13():9-19. PubMed ID: 30587940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of poor medication adherence on clinical outcomes and health resource utilization in patients with hypertension and/or dyslipidemia: systematic review.
    Kengne AP; Brière JB; Zhu L; Li J; Bhatia MK; Atanasov P; Khan ZM
    Expert Rev Pharmacoecon Outcomes Res; 2024 Jan; 24(1):143-154. PubMed ID: 37862440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular Quality of Care Assessment: Clinicians' Adherence to Lipid-Lowering Therapy for Patients with Atherosclerotic Cardiovascular Disease.
    Chan J; Rajalingam T; Fossella J; Zhou H; Eisenberg N; Roche-Nagle G
    Ann Vasc Surg; 2020 Nov; 69():197-205. PubMed ID: 32554202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a fixed-dose combination strategy on adherence and risk factors in patients with or at high risk of CVD: the UMPIRE randomized clinical trial.
    Thom S; Poulter N; Field J; Patel A; Prabhakaran D; Stanton A; Grobbee DE; Bots ML; Reddy KS; Cidambi R; Bompoint S; Billot L; Rodgers A;
    JAMA; 2013 Sep; 310(9):918-29. PubMed ID: 24002278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol: a randomized controlled trial.
    Lee JK; Grace KA; Taylor AJ
    JAMA; 2006 Dec; 296(21):2563-71. PubMed ID: 17101639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood pressure and lipid target adherence in Korean patients receiving angiotensin II receptor blockers/statin regimens.
    Kim HJ; Kim E; Min KB; Min JY
    Curr Med Res Opin; 2017 Feb; 33(2):385-390. PubMed ID: 27819152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein apheresis: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(5):1-101. PubMed ID: 23074505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of risk factors among ambulatory patients at high cardiovascular risk in Canada: a follow-up study.
    Elbarasi EA; Goodman SG; Yan RT; Tan MK; Hackam DG; Leiter LA; Langer A; Yan AT;
    Can J Cardiol; 2013 Dec; 29(12):1586-92. PubMed ID: 24041994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applying the evidence: do patients with stroke, coronary artery disease, or both achieve similar treatment goals?
    Saposnik G; Goodman SG; Leiter LA; Yan RT; Fitchett DH; Bayer NH; Casanova A; Langer A; Yan AT; ; ;
    Stroke; 2009 Apr; 40(4):1417-24. PubMed ID: 19213947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medication adherence among persons with coronary heart disease and associations with blood pressure and low-density-lipoprotein-cholesterol.
    Pedersen E; Primicerio R; Halvorsen KH; Eggen AE; Garcia BH; Schirmer H; Waaseth M
    Eur J Clin Pharmacol; 2022 May; 78(5):857-867. PubMed ID: 35061046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants for achieving the LDL-C target of lipid control for secondary prevention of cardiovascular events in Taiwan.
    Ho LT; Yin WH; Chuang SY; Tseng WK; Wu YW; Hsieh IC; Lin TH; Li YH; Huang LC; Wang KY; Ueng KC; Fang CC; Pan WH; Yeh HI; Wu CC; Chen JW;
    PLoS One; 2015; 10(3):e0116513. PubMed ID: 25756522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective analysis of LDL-C goal achievement and self-reported medication adherence among statin users in primary care.
    Bermingham M; Hayden J; Dawkins I; Miwa S; Gibson D; McDonald K; Ledwidge M
    Clin Ther; 2011 Sep; 33(9):1180-9. PubMed ID: 21840055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DemographIc Assessment and EValuation of DEgree of Lipid Control in High Risk Indian DySlipidemia PatiEnts (DIVERSE Study).
    Malhotra N; Keshan MK; Agarwal A; Kumar RA; Trailokya A; Dalvi K; Talele S
    J Assoc Physicians India; 2016 Apr; 64(4):38-46. PubMed ID: 27734640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Statin therapy in Canadian patients with hypercholesterolemia: the Canadian Lipid Study -- Observational (CALIPSO).
    Bourgault C; Davignon J; Fodor G; Gagné C; Gaudet D; Genest J; Lavoie MA; Leiter L; McPherson R; Sénécal M; Marentette M; Sebaldt RJ
    Can J Cardiol; 2005 Nov; 21(13):1187-93. PubMed ID: 16308595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2017 Taiwan lipid guidelines for high risk patients.
    Li YH; Ueng KC; Jeng JS; Charng MJ; Lin TH; Chien KL; Wang CY; Chao TH; Liu PY; Su CH; Chien SC; Liou CW; Tang SC; Lee CC; Yu TY; Chen JW; Wu CC; Yeh HI;
    J Formos Med Assoc; 2017 Apr; 116(4):217-248. PubMed ID: 28242176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
    Querton L; Buysschaert M; Hermans MP
    J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical and psychosocial factors and unfavourable low-density lipoprotein cholesterol control in coronary patients.
    Munkhaugen J; Sverre E; Otterstad JE; Peersen K; Gjertsen E; Perk J; Gullestad L; Moum T; Dammen T; Husebye E
    Eur J Prev Cardiol; 2017 Jun; 24(9):981-989. PubMed ID: 28196429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.